SCHEMBL21596476

SCHEMBL21596476

CCCOC(=O)c1cc(Br)cnc1Cl.CCCOC(=O)c1cc(I)cnc1Cl.CCOC(=O)c1cc(Br)cnc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 6/20 0.40
NPSR1 Q6W5P4 2/20 0.39
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TP53 P04637 1/20 0.39
CASP1 P29466 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 1/20 0.38
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
GAA P10253 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21596477 0.96 OPRK1 (0.40) OPRK1NPSR1POLBTSHRHSD17B10
SCHEMBL28522607 0.89 ALDH1A1 (0.46) TSHRHSD17B10TP53CASP1ALDH1A1
SCHEMBL28533997 0.89 ALDH1A1 (0.46) OPRK1HSD17B10TP53ALDH1A1GABRA2
SCHEMBL2782609 0.86 OPRK1 (0.48) OPRK1NPSR1POLBTSHRHSD17B10
SCHEMBL9383978 0.86 CASP1 (0.47) TSHRCASP1ALDH1A1GABRA2MEN1
SCHEMBL3695889 0.74 CYP1A2 (0.44) OPRK1NPSR1POLBTSHRHSD17B10
SCHEMBL20472461 0.73 ALDH1A1 (0.50) OPRK1NPSR1POLBTSHRHSD17B10
SCHEMBL5864153 0.72 OPRK1 (0.50) OPRK1NPSR1POLBTSHRHSD17B10
SCHEMBL6715621 0.72 KDM4E (0.49) TSHRHSD17B10ALDH1A1GABRA2MEN1
SCHEMBL3582809 0.72 CASP1 (0.49) TSHRCASP1ALDH1A1MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810585-A1 PROCESS FOR PREPARING TRICYCLIC COMPOUNDS Bayer Aktiengesellschaft (DE) 2021-04-28 EP disclosed
WO-2019243243-A1 PROCESS FOR PREPARING TRICYCLIC COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2019-12-26 WO disclosed